Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.

Saved in:
Bibliographic Details
Title: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Authors: Luszczak S; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Simpson BS; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Sathyadevan VK; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Echeverria LMC; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Kumar C; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Costa H; Research Department of Pathology, University College London, London, UK., Haider A; Research Department of Pathology, University College London, London, UK., Freeman A; Research Department of Pathology, University College London, London, UK., Jameson C; Research Department of Pathology, University College London, London, UK., Ratynska M; Research Department of Pathology, University College London, London, UK., Ben-Salha I; Research Department of Pathology, University College London, London, UK., Sridhar A; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK., Shaw G; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK., Kelly JD; Department of Uro-Oncology, UCLH NHS Foundation Trust, London, UK., Pye H; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Gately KA; Trinity Translational Medicine Institute, St. James's Hospital Dublin, Dublin 8, Ireland., Whitaker HC; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, University College London, London, UK. s.heavey@ucl.ac.uk.
Source: Scientific reports [Sci Rep] 2020 Sep 01; Vol. 10 (1), pp. 14380. Date of Electronic Publication: 2020 Sep 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2045-2322
DOI:10.1038/s41598-020-71263-9